Drugs commonly used to treat high blood pressure, and prevent heart attacks and strokes, are associated with significantly worse cardiovascular outcomes in hypertensive African Americans compared to whites, according to a new comparative effectiveness research study led by researchers in the Department of Population Health at NYU Langone Medical Center. Show
The study, published on September 15 in the Journal of the American College of Cardiology (JACC), is unique, the authors say, in that it evaluates racial differences in cardiovascular outcomes and mortality between hypertensive black and white patients whose treatment was initiated with angiotensin-converting-enzyme (ACE) inhibitors, outside of a clinical trial. ACE inhibitors are one of several classes of drugs commonly prescribed to individuals with hypertension to prevent deaths, heart attack, kidney failure, heart failure, and stroke. Evidence from randomized controlled trials has previously indicated that ACE inhibitors may not provide the same benefits in blacks compared to whites. However, blacks have been largely underrepresented in the majority of these studies, despite the fact they have disproportionately higher rates of hypertension-related morbidity and mortality than other racial and ethnic groups, according to study authors. “We know what works in clinical trials. But when you go into the real world clinical practice setting, physicians don’t often translate that evidence into practice. This is the first study that looks at this issue in a real-world, clinical practice setting,” says Gbenga Ogedegbe, MD, MPH, lead author of the study and a professor in the Department of Population Health at NYU Langone. Data for the study came from electronic health records of nearly 60,000 patients who have high blood pressure and received care between 2004-2009 within New York City’s Health and Hospital Corporation (HHC). HHC operates all public hospitals and clinics in New York City and is the largest such institution in the country. Approximately 35 percent of patients seen in the HHC system are African American. The investigators compared rates of all-cause mortality, heart attack, stroke, and congestive heart failure between African American and white patients who were prescribed one of four classes of antihypertensive drugs to treat high blood pressure: ACE inhibitors, beta blockers, calcium-channel blockers, or thiazide-type diuretics. In African Americans, ACE inhibitor use was associated with a statistically significant rate of poorer cardiovascular outcomes (8.7 percent compared to 7.7 percent) but not in whites (6.4 percent compared to 6.74 percent). African Americans were no more likely than whites to have adverse effects linked to use of ACE inhibitors. The reasons for the noted racial disparity in clinical effectiveness of ACE inhibitor-based regimes between African Americans and whites remain unclear, though the prevailing theory is that blacks are less responsive to antihypertensive treatment with ACE inhibitors. African Americans are also at greater risk for cardiovascular events than whites. “The results of this study adds to a growing consensus among physicians that treatment of hypertension in blacks should not be initiated with ACE inhibitors,” said Dr. Ogedegbe, director of Division of Health & Behavior and NYU’s Center for Healthful Behavior Change. In January, the Joint National Committee recommended initiating other treatments besides ACE inhibitors in patients of African descent, and there are other guidelines in preparation that can be informed by this study, Dr. Ogedegbe noted. Additional authors of the study include other NYU Langone researchers Sripal Bangalore, MD, and Keith Goldfeld, DrPH. Dr. Ogedegbe was supported by a grant from the National Heart, Lung, and Blood Institute, K24HL111315, in addition to the AHRQ grant R01HS018589. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The AHRQ did not have any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of this manuscript. Media InquiriesAllison Clair High blood pressure, also known as hypertension, affects Black people in unique ways. It's known to: Why is high blood
pressure in Black people so common? If you are Black, what can you do to avoid having high blood pressure? Find out how you can protect yourself from this serious health condition. Researchers do not have
a definitive answer to this question, but some believe the following things have something to do with it: Researchers will hopefully find the causes for the high incidence of high blood pressure in Black people. In the meantime, there is a lot you can do to keep high blood
pressure from damaging your health. Being Black is a risk factor for developing high blood pressure. Others include: The more risk factors you have, the more likely it is that you have high blood pressure or will get it in the future. Take steps now to find out more. Even if you don't have high blood pressure, you can lower your risk by following the treatment guidelines for high blood pressure in Black people. Your doctor can easily measure blood pressure. A blood pressure reading includes two numbers, one written on top of the other. The top number is called your systolic blood pressure. This number represents the force of blood through your blood vessels during your heartbeat. The bottom number is called your diastolic blood pressure. This number represents the force of blood through your blood vessels in between heartbeats, while your
heart is resting.
Blood pressure changes throughout the day, depending on your activities. Blood pressure changes over time, as well. Systolic blood pressure tends to rise as you get older. Diastolic blood pressure may decrease as you get older. If either of your blood pressure readings is consistently above normal, then take action right away. Work with your doctor to develop a plan to treat high blood pressure before damage to your organs occurs. Treating High Blood Pressure in Black PeopleIf you have high blood pressure, consult your doctor to find which combination of treatments works best, given your individual health and lifestyle. Your treatment plan is likely to include the following elements:
Making Your High Blood Pressure Treatment Plan WorkTo be sure your high blood pressure treatment plan is working, follow these steps:
Your knowledge about the risk of high blood pressure in Black people is the first step in controlling this condition, so you can remain as healthy as possible for years to come. Is losartan good for Black patients?Conclusions: The results of this study suggest that in African American patients, losartan monotherapy was significantly more effective than placebo in lowering SiSBP and SiDBP.
What blood pressure medication should African Americans avoid?In African Americans, ACE inhibitor use was associated with a statistically significant rate of poorer cardiovascular outcomes (8.7 percent compared to 7.7 percent) but not in whites (6.4 percent compared to 6.74 percent).
What is first line treatment for hypertension in African American?First‐line therapy for the treatment of hypertension in African Americans as recommended by JNC VI includes diuretics or a low‐dose combination of a diuretic and β blocker. Calcium channel antagonists are an acceptable alternative when added to previously existing diuretic monotherapy.
What does lisinopril do to Black people?However, lisinopril was associated with an increased risk for heart failure (relative risk [RR] for African Americans=1.32; 95% CI, 1.11–1.58) and stroke (RR for African Americans=1.4; 95% CI, 1.17–1.68), and amlodipine was associated with a higher risk of heart failure (RR in African Americans=1.47; 95% CI, 1.24–1.74) ...
|